← FDA Drug Approvals (Drugs@FDA)
EMBEDA
NDA · New Drug Application · Sponsor: ALPHARMA PHARMS · Approved 2009-08-13
Drug application
- FDA Application #
NDA022321
- Application type
- New Drug Application
- Brand name
- EMBEDA
- Generic name
- Morphine Sulfate
- Active ingredients
- MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ALPHARMA PHARMS
- First approval
- 2009-08-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown